$PLTR can't stop winning.

Here's their biggest wins in the last 6 months of 2024 👇 1. US Army x $PLTR

Extended long-standing partnership with the US Army.

The total value of this is $400M with a total available ceiling up to $618.9M for a period of 4 years.

These 10 stocks are trading below 10x NTM EV/Sales but offer +30% YoY revenue growth (and are profitable) 👇🧵

1. MercadoLibre | $MELI

EV/Sales: 3.5x
Revenue Growth: 35.3%
Net Income Margin: 7.5%

$MELI trades near it's 2022 EV/Sales lows despite:
- Increasing revenue ~$8.5 billion
- Growing Argentina and Mexico revenue by over 2x
- More than doubling total payment transactions 2. StepStone Group | $STEP

EV/Sales: 6.3x
Revenue Growth: 41.9%
Net Income Margin: 6.5%

The wealth management industry is estimated to grow at 8% CAGR through to 2030 so demand for a company like $STEP should sustain. Not a bad investment, I just think there's much better out there.

$NU is going to struggle for at least the next 12 months.

I believe we will see a single digit stock price over the next 3-4 months.

However, this is the perfect time to DCA and build a very strong $NU position.

Let me remind you why $NU will be ok long term👇 Let's just first clarify what's happening in Brazil 👇

Brazil has had a difficult couple months:
1. Their budget deficit plan was not as good as it needed to be (or investors wanted it to be)
2. Consumer confidence and investor sentiment hit a low.
3. The Brazilian Real hit a record low vs USD dropping 21% in 1Y.

This man knows the market:

He has predicted:
1. The Dot-Com Bubble (2000)
2. The Global Financial Crisis (2008)
3. Japan's Asset Bubble (1989)
4. The COVID Bubble (2021-2022)

Here is Jeremy Grantham's latest warning 🧵 Grantham is the co-founder and chief investment strategist at GMO.

GMO had $118 billion in AUM in 2015.

Grantham has consistently predicted market bubbles and been a prominent voice warning people of market crashes.

So when he talks, people listen 👇

I think these 5 stocks are no brainers to DCA into now👇

1. TransMedics | $TMDX

$TMDX had fleet maintenance issues in Q3. Being the only medtech to take full control over their supply chain will likely come with some challenges, but I trust with the strong Command Center they have, these maintenance issues and logistics control won't be a long-term issue.

The other reason for the drop in the share price was seasonal declines in the transplant volume, particularly for heart and lung. Management warned investors about this in Q2, so there's no reason for this to be such a shock.

$TMDX is more than just an innovative medtech now. They're an innovative medtech, with the best transplant transportation product in the market, as well as a newly growing logistics company that will have the ability to serve 20,000-30,000 transplants per year soon. 2. Uber | $UBER

$UBER is trading at 2021 prices. In the last 3 years since 2021, $UBER has:

- Doubled revenues
- Become consistently profitable
- Announced plans to tackle rural areas
- Announced partnerships with 8 different AV companies
- Gone from negative $450m in FCF to positive $2.11b in FCF

Here's 10 of the best stocks in 10 of the most exciting niches 👇

1. NuBank | $NU

Niche: LatAm fintech

$NU has rapidly become one of largest fintechs globally, let alone in LatAm.

- In Q3, $NU added 5.2 million new customers. They are completely dominant in Brazil where they now have over 100 million customers.
- They added 13% of their Mexico customer base in Q3 alone.
- Mature accounts in Brazil now have an ARPAC of $25 (far higher than the average of $11) which shows the stickiness of the platform over time. 2. TransMedics | $TMDX

Niche: Med Tech

- The recent investor day was very strong. Management stated that their goal is FAR more than 10,000 transplants annually.
- The new Command Center at HQ highlights the complete control that $TMDX have over the entirety of their logistics. No other competitor has this.
- They have big plans for international expansion and kidney transplants over the next few years.

Here's my $GRAB investment thesis.

🧵 $GRAB are building the everything app in Southeast Asia - ride hailing, food delivery, digital payments, and more.

Here's a very brief overview of my bullish case:

1. Huge TAM.
2. Great fundamentals
3. Strong cross-selling
4. Diversified portfolio

Here's 10 stocks with the best fundamentals👇

🧵

1. Hims & Hers | $HIMS

- No debt
- 77% growth
- 79% gross margin
- 20% FCF margin
- $67 monthly online revenue per customer 2. Palantir | $PLTR

- 30% YoY growth
- 80% gross margin
- $0.18 FCF per share
- 57% FCF margin

HERE'S THE ULTIMATE THREAD 👇

I've consolidated all my threads on the highest quality stocks into this one thread🧵

$NU $PYPL $TMDX $HIMS $PLTR $SOFI $ASML $AMZN

Enjoy 👇 1. NuBank | $NU

Full investment thesis 👇

https://x.com/MMMTwealth/status/1864029957044727968

Full $NU investment thesis 👇

(THREAD 🧵) $NU is the largest fintech in Latin America and one of the largest in the world.

To put it into perspective, they have 109.7 million customers and 91.7 million monthly active customers with 100 million of these being in Brazil.

The population of adults between 16-65 in Brazil is 143 million meaning they've acquired 70% of Brazil's population. That's incredible.

To add to this, $NU are growing incredibly fast in Mexico and Colombia and I think Argentina will be the next area for investment in 2-3 years.

This thread will dive into what $NU does, the valuation, competitors, financials, opportunities, recent news, and the LatAm outlook.

The US stock market is valued very high.

It's time to start considering investing in places outside of the US.

Here's the highest quality international stocks at a cheap valuation👇

(A thread🧵) 1. Evo AB | $EVO 🇸🇪

Revenue growth: 17%
EV/Sales: 8.58x
EV/FCF: 14.03x

$EVO have been fairly flat for the last 3 years despite increasing revenue 17% in the last year, and net profit 14% in the year.

IF YOU'RE INVESTING INTO $SMCI CURRENTLY, I SUGGEST YOU READ THIS THREAD FIRST.

Here's a detailed explanation explaining exactly what's happened, and quite frankly why I believe it's idiotic to invest into $SMCI today.

(thread🧵) $SMCI has been on a crazy ride in 2024.

The stock rose from $28 in January to $115 in March - a 307% increase in 3 months.

It then dropped down to $18 by 15th November 15th...erasing 85% of it's market cap.

(chart from @stocksguide_ )

Economic moats are everything in investing.

Here's 10 of the most undervalued stocks in the market with the widest moats.

(THREAD🧵)

1. ASML | $ASML

P/S: 9.63x
P/E: 36.46x
Revenue Growth: (2%)

$ASML have a huge economic moat in terms of their technical advantage in EUV lithography. They also have suppliers that ONLY supply $ASML meaning no competitors can get hold of the tech that $ASML use and never will. 2. SoFi | $SOFI

P/S: 4.66x
P/E: 131.9x
Revenue growth: 40%

$SOFI has broken out of its $6-7 range but it's still undervalued based on it's growth rates, cross-selling capabilities, & margin expansion all for a P/S of 4.66x.

$SOFI are building a one-stop shop for all things finance and their tech platform is slowly becoming the go-to for all financial institutions like $HOOD.

These 10 stocks were the best performing S&P 500 stocks in 2017 when Trump was president👇

(THREAD🧵) 1. Align Technology | $ALGN

% Performance: 131%
Revenue Growth: 1.84$
EV/Sales: 3.8x

Here's 10 stocks that I've added to my watchlist in the last 2 months👇🧵

1. TransMedics | $TMDX

I initiated a position in $TMDX post earnings drop and I'll be DCA'ing with any further moves down.

I don't know yet if this is short term noise or a more structural change in the quality of the business but this chart is positive. 2. ASML | $ASML

$ASML has a monopoly in EUV lithography technology - vital for making chips more compact.

I'm DCA'ing down on this one too. I think this has almost guaranteed good returns over the next 5 years.

UBS just released 29 companies they believe will be the strongest through to 2030.

Most of them are very expensive already and not worth buying today.

I picked out the best 5 for you here 👇

THREAD (🧵) 1. Taiwan Semiconductor | $TSM

Revenue Growth: 38.95%
Net Margin: 42.81%
EV/Sales: 10.2x

Commentary: Maybe $TSM can't be considered "cheap" but I'd argue they're definitely worth the premium they're trading for.

In Q3 earnings management were very sure that AI-related demand is "extremely robust" until late 2025 where they forecasted revenue from server AI processors to more than triple this year.

$TSM are also investing heavily into fabs in Arizona, Japan, and Germany to de-risk themselves from the China-Taiwan tensions, provide more flexibility for clients, and create a much stronger economies of scale. Although this will put pressure on margins over the next few years, $TSM will have one of the strongest cost efficiencies in the market in 10 years.

Michael Burry has had a sensational 2024 so far. His fund is up 39%.

Over the last 8 years he has also managed to provide returns of 345% compared to 110% for the S&P 500...!

He only holds 10 companies. Want to see them?

🧵👇 1. Alibaba | $BABA

Revenue Growth: 3.88%
EV/Sales: 1.9x

Commentary: $BABA has been one of the stocks of the last month and I'm glad I hold it. With the stock at $113 now I still believe there is a lot more room to run and I won't be trimming until the $125+ range.

$BABA is still one of the cheapest and most diversified companies in the world and their cloud sector is set to dominate in China.

Howard Marks has returned 23% annually over the last 25 years.

He also said that 95% of his investments have led to a positive return.

Here's his top 10 holdings right now (I guarantee you won't have heard of most of them)

👇🧵 1. Torm Plc | $TRMD

% of portfolio: 27.38%
Revenue growth: 13.9%

What it does: $TRMD is a product tanker company engaging in the transport of refined oil products and crude oil worldwide.

Investing is all about risk to reward.

Here's 10 stocks with incredible risk to reward opportunities today:

1. $CELH

Revenue growth: 23.55%
EV/Sales: 5.1x

$CELH has been punished for slowing revenue growth, but this was completely expected. No company can sustainably grow in the triple digits for 4-5 years.

$CELH is now a margin and earnings expansion story along with consistent international growth. They'll continue to eat away at market share. 2. $PLTR

Revenue growth: 27.2%
EV/EBITDA: 61.7x

There's no denying $PLTR is expensive and I wouldn't buy at NTM 61.7x EV/EBITDA. However, any drops below the $30s I'd become very interested in adding to my position.

$PLTR are dominating their niche and AIP is set to become fundamental to business success.

Tracking margin expansion can lead to incredible investment opportunities.

Here's 5 stocks with huge margin expansion potential👇🧵

1. SentinelOne | $S

Gross Margin: 73.1%
Net Margin: -37.6%
Net Margin 12 Months Ago: -80.1%

2 years behind $CRWD, I believe $S has huge room for growth in the cybersecurity space. 2. Palantir | $PLTR

Gross Margin: 81%
Net Margin: 19.8%
Net Margin 12 Months Ago: 5.3%

I think we all know I'm a huge fan of $PLTR. Huge revenue growth and huge margin expansion.

Yesterday $MSFT CEO said $PLTR was the "leader in their industry". HUGE SHOUT-OUT!

Here's 5 simple reasons why $PLTR is one of the best investments for the next decade👇📈 1/ $PLTR are one of the clear leaders in a booming industry.

We are quickly moving towards commoditizing anything that can be produced by a machine.

The key to this is data.

The collection, analysis, and utilization of data will be one of the most important activities in business. This is $PLTR.